Company Search:
Advanced Search
Sponsored Links
Regeneron Pharmaceuticals Incorporated Company Snapshot
Regeneron Pharmaceuticals Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regeneron Pharmaceuticals Incorporated with three other companies in this sector in UNITED STATES : Zoetis Inc (2019 sales of $6.26 billion of which 51% was US), Daiichi Sankyo Company Limited ($8.38 billion of which 93% was Prescription drugs), and CSL Limited ($8.54 billion of which 84% was CSL Behring).

Sales Analysis. Regeneron Pharmaceuticals Incorporated reported sales of $7.86 billion for the year ending December of 2019. This represents an increase of 17.2% versus 2018, when the company's sales were $6.71 billion. Sales at Regeneron Pharmaceuticals Incorporated have increased during each of the previous five years (and since 2014, sales have increased a total of 179%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Regeneron Pharmaceuticals Incorporated
  Stock Performance Chart for Regeneron Pharmaceuticals Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 599.74
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks 8.0%  
4 Weeks -6.9%   52 Weeks 99.8%  
Regeneron Pharmaceuticals Incorporated Key Data:
  Ticker: REGN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 7,863,400,000
(Year Ending Jan 2020).
Employees: 8,100
  Currency: U.S. Dollars Market Cap: 63,589,629,148
  Fiscal Yr Ends: December Shares Outstanding: 106,028,661
  Share Type: Common Closely Held Shares: 4,733,009
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.